Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Taiwan / NCT07334938
Active, not recruiting Not applicable

Effects of Far Infrared Rays and Transcutaneous Electrical Nerve Stimulation on Short Term Prognosis of Head and Neck Cancer Patients Receiving Curative Treatment

NCT07334938 · tracked via the Priya Life Science Taiwan tracker
Sponsor
Buddhist Tzu Chi General Hospital
Phase
Not applicable
Started
2024-05-01
Last updated
2026-01-13

Condition(s) studied

Head and Neck Cancer (H&N)

Investigational drug(s) / intervention(s)

Transcutaneous Electrical Nerve Stimulation (TENS)Far-Infrared Therapy

Transcutaneous Electrical Nerve Stimulation (TENS): Transcutaneous electrical nerve stimulation is applied to the neck region twice daily, in the morning and evening, for five consecutive days.

Far-Infrared Therapy: Far-infrared therapy is applied to the neck region twice daily, in the morning and evening, for five consecutive days.

Study summary

The goal of this clinical trial is to determine whether far-infrared therapy and transcutaneous electrical nerve stimulation (TENS) can improve postoperative side effects in patients with head and neck cancer. The main questions this study aims to answer are:

Can far-infrared therapy and transcutaneous electrical nerve stimulation reduce pain and improve neck range of motion?

Can far-infrared therapy and transcutaneous electrical nerve stimulation reduce inflammation?

Researchers will compare three groups:

Group A: control group; Group B: transcutaneous electrical nerve stimulation; Group C: far-infrared therapy combined with transcutaneous electrical nerve stimulation, to evaluate differences in pain, neck range of motion, and inflammation.

Participants will receive the assigned intervention in the morning and evening for five consecutive days. Outcome measurements will be conducted on the first and fifth days.

Eligibility

Sex
ALL
Min age
30 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria 1. Patients aged 30 to 85 years with a confirmed diagnosis of head and neck cancer. 2. Patients scheduled to undergo surgical resection. 3. Patients who are conscious, able to communicate verbally or in writing, and willing to complete questionnaires and comply with all study procedures. Exclusion Criteria: 1. Presence of open wounds or skin lesions at the sites where transcutaneous acupoint electrical stimulation electrodes would be applied. 2. Contraindications to transcutaneous acupoint electrical stimulation, including a history of epilepsy, brain tumors, arteriovenous malformations, or implanted cardiac pacemakers or defibrillators, to avoid potential adverse effects of electrical stimulation.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation Hualien City Hualien County

More Buddhist Tzu Chi General Hospital trials in Taiwan

Exploring the Effects of Transcutaneous Electrical Acupoint Stimulation Therapy on Patients After Video-Assisted Thoracoscopic Surgery Enrolling by invitation
Epidural Electrical Stimulation for Stroke Patients - Improve Motor and Sensory Function and Alleviate Pain Recruiting
Assessing the Magnitude of Anisometropia in Patients Wearing Misight 1 Day Contact Lens Enrolling by invitation
Exploration of the Effectiveness and Mechanism of Personalized Epidural Electrical Stimulation in Improving Upper Limb Function in Participants With Spinal Cord Injury Recruiting
The Use of Molecular Radiogenomics in Non-small Cell Lung Cancer Recruiting

Other trials for the same condition

Effects of Far Infrared Rays and Transcutaneous Electrical Nerve Stimulation on Short Term Prognosis of Head and Neck Cancer Patients Receiving Curative Treatment Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07334938 on ClinicalTrials.gov ↗ ← All trials in Taiwan